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The most modern techniques in biotechnology owe their 
existence to the discovery of DNA cloning and the genetic 
manipulation of organisms. However Biotechnology is not new 
science In fact, many applications represent old practices with 
new methodologies. Human have been used organisms for their 
benefit in many processes for several thousand years. Therefore, 
one way of thinking about biotechnology is to consider two 
categories of activities: those that are traditional and familiar and 
those that are relatively new. Study of ethical and social concern 
in these categories makes this clear that there are many 
unanswered questions in this fields that requires caution 
regarding to public using of this technologies. 
Genetic manipulation (GM) especially cloning is a wonderful 
advancement in technology and knowledge. However, 
Professional and scientific societies should make clear that any 
attempt to create a child by somatic cell nuclear transfer and 
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implantation into a woman's body would be at this time an 
irresponsible, unethical, and unprofessional act. The 
environmental safety aspects of GM crops vary considerably 
according to local conditions. Different GM organisms include 
different genes inserted in different ways. This means that 
individual GM foods and their safety should be assessed on a 
case-by-case basis and that it is not possible to make general 
statements on the safety of all GM foods. 




Biotechnology is most briefly defined as the art of utilizing 
living organisms and their products for the production of food, 
drink, medicine or for other benefits to the human race, or other 
animal species. Technically speaking, humans have been using 
biotechnology since they discovered farming, with the planting 
of seeds to control plant growth and crop production. Animal 
breeding is also a form of biotechnology. More recently, cross-
pollination of plants and crossbreeding of animals were macro-
biological techniques in biotechnology, used to enhance product 
quality and/or meet specific requirements or standards. The 
discovery of microorganisms and the subsequent burst of 
knowledge related to the causes of infectious diseases, 
antibiotics and immunizations could probably be counted among 
man’s most significant, life-altering discoveries. 
However, the most modern techniques in biotechnology owe 
their existence to the discovery of DNA cloning and the genetic 
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Biotechnology is not new science In fact, many applications 
represent old practices with new methodologies. Human have 
been used organisms for their benefit in many processes for 
several thousand years. Historical accounts have shown that 
Chinese, Greeks, Romans, Babylonians and Egyptians among 
many others have been involved in biotechnology since nearly 
2000 B.C. Therefore, one way of thinking about biotechnology is 
to consider two categories of activities: those that are traditional 
and familiar and those that are relatively new. Within each 
category can be found technologies that are genetic-that involve 
modifications of traits passed down from one generation to the 
next-and technologies that are not. In addition, there are 
interesting issues connected with a number of biotechnologies 
such as old and new. 
 
A. Traditional and old Biotechnologies 
A prime example of traditional genetic biotechnologies is 
selective breeding of plants and animals. The rudiments of 
selecting plants and animals with desirable traits and breeding 
them under controlled conditions probably go back to the dawn 
of civilization, but the expansion of knowledge about genetics 
and biology in this century has developed selective breeding into 
a powerful and sophisticated technology. New molecular 
approaches like marker-assisted breeding (which enhances 
traditional breeding through knowledge of which cultivars or 
breeds carry which trait) promise to enhance these approaches 
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Traditional breeding technologies have been immensely 
successful, and indeed are largely responsible for the high yields 
associated with contemporary agriculture. These technologies 
should not be considered passé or out of date. For multi gene 
traits like intrinsic yield and drought resistance, they surpass 
genetic engineering. This is because selective breeding operates 
on whole organisms -complete sets of coordinated genes- while 
genetic engineering is restricted to three or four gene transfers 
with little control over where the new genes are inserted. For the 
most important agronomic traits, traditional breeding remains the 
technology of choice. 
Other traditional nongenetic biotechnologies include the 
fermentation of microorganisms to produce wine, beer, and 
cheese. Industry also uses microorganisms to produce various 
products such as enzymes for use in laundry detergents. In an 
effort to find microorganisms that produce large amounts of 
enzymes, scientists sometimes treat a batch of organisms with 
radiation or chemicals to produce randomly genetic alternations. 
The process, called mutagenesis, produces numerous genetic 
changes in the bacteria, among which might be a few that 
produces more of the desired product. 
  
B. Biotechnology Today 
Biotechnology does not mean hunting and gathering animals and 
plants for food. However domesticating animals like sheep and 
cattle for use as livestock is a classic example of biotechnology. 
Our early ancestors also took the advantage of microorganisms   
and used fermentation to make breads, cheeses and yogurts. 

















Quarterly Journal of Medical Ethics          Vol 2, No 5, Fall 2008 
sectors of industry today. There are, of course, the obvious 
medical, pharmaceutical and food industries.  
Advances in biotechnology are being used to determine cause 
and effect of various diseases and are used in the production of 
drugs. The production of foods is enhanced by biotechnological 
advances that improve crop yields, introduce in-situ insect 
resistance and provide new ways of food preservation. 
Technological advances also include biodegradable packaging 
and built-in bio-indicators of food contamination. In the 
environmental sector, biotech has played a role in remediation of 
contaminated land, water and air, pest control, treatment of 
industrial effluents and emissions, and acid mine drainage. 
Moral debates in bioethics continue to surround the field of 
biotechnology. The public response to issues such as the value of 
genetically modified organisms (GMOs), versus the risks 
involved in their release into the environment, more-or-less 
quenched the enthusiasm of the bioremediation industry for 
GMO research, in the early 1980’s. Genetically modified foods 
(GMFs) continue to be produced, but with more and more 
governments clamping down on production and distribution and 
answering calls by the public demanding strict testing and 
labeling procedures. 
Exciting new developments are being made in bio-fuel research, 
at a time when fossil fuel prices as sharply increasing. However, 
the question of whether a diminishing supply can meet the ever-
increasing demand is under debate by those who do not believe 
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some question of whether the cost of biofuel research and 
development is worth the effort. 
Finally, there are the highly publicized and emotional debates 
surrounding the use of human embryos and stem cells for genetic 
research. Although the benefits of such research are obvious to 
most, the cost to human rights, morality and religious integrity 
are too high for some. 
C. Broad Spectrum of Biotechnological Applications 
Today the known applications for biotechnology can be seen as a 
broad spectrum. Biotechnology is generally divided into 
following sub fields – blue, red, white or grey and green 
biotechnology.  
 
1. Blue Biotechnology 
It applies to marine or aquatic applications such as restoring and 
preserving various aquatic species, such as blue crabs in the 
Chesapeake Bay. A second example is land-based marine 
aquaculture that is  based on methods for large-scale hatching 
and growth of marine fishes in a completely self-contained 
recirculating environment. 
  
2. Red Biotechnology 
Red biotechnology deals with genetically altered 
microorganisms that are used for producing products like insulin 
and vaccine for medical use. It is through red biotechnology 
based research that antibiotics for different infections have been 
developed and vaccines for boosting the immune system against 
disease and to detect and treat any genetic disorders and disease 
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reproductive technologies like in vitro fertilization, DNA 
profiling, forensics and in technologies of transplantations.  
 
3. White (Grey) Biotechnology 
It involves the creation of useful chemicals for the industrial 
sector through organisms like moulds or yeast. This form of 
biotechnology is also referred to as grey biotechnology.  It is 
with the help of white biotechnology that the environment is 
helped in the control of pest animals and plants. Biotechnology 
has helped in cleaning up oil spills, protecting endangered 
species by storing DNA samples to be used for future research 
and to help remove any excess nutrients there may be in the soil 
and water. Research in biotechnology also aims at leaching 
metals from the soil to provide for clean mining, in the detection 
of landmines and in the cleaning of arsenic and other metal 
contamination. An important example of bioremediation is 
microbe that is utilized to clean up toxic to hazardous industrial 
wastes in the environments, such as PCBs. 
 
4. Green Biotechnology 
Green biotechnology, also known as agricultural biotechnology, deals 
with applications related to agriculture such as production of disease 
resistant or UV resistant plants. Green biotechnology involves the 
manipulation of plants and animals to produce species that are more 
environments friendly and productive. Development of varieties of 
wheat that are disease resistant by crossbreeding different types of 
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5. Multicolored Biotechnology 
Biotechnology is often multidisciplinary, and so many 
applications may be classified in more than one ‘color’ category. 
For example, the production of biodiesel from agricultural or 
waste materials could be considered both white green, or white 
and blue biotechnology. 
 
D. Ethics and Bioethics 
Scientific research into human genetics has been a continuing a 
source o intriguing, and at times formidable, ethical issues. The 
recent world wide interest in a project to map and ultimately 
sequence the estimated three billion base pairs of the genome has 
generated controversy over the effect such knowledge might 
have on us, as well as about the wisdom of investing so much 
research funding.  The question is largely a matter of science 
policy rather than ethics. As an investment of scarce resources, 
the genome initiative may not be the wisest at this time. 
However, even so, it is not the wisest way to spend research 
resources; it would not make it unethical. The confusion may lie 
in the profligate manner in which epithet such as unethical or 
immoral are used to tarnish a person or enterprise we do not like. 
It is difficult to define ethics comprehensively. In general, the 
ethics is the branch of philosophy concerned with how we should 
decide what is morally wrong or right. Sometimes the Words 
‘ethics and morals are used interchangeably. Ethics, though, is a 
specific discipline that tries to probe the reasoning behind our 
moral life particularly by critically examining and analyzing the 
thinking that is or could be used to justify our moral choices and 
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be difficult to find, but there is considerable agreement on the 
meaning of bioethics.  
Bioethics is simply an application of moral principles in the 
Biological Sciences that are applied in the different research 
fields especially in medicine, health care and the life sciences; a 
systematic discipline that applies moral philosophy to healthcare 
practices. Bioethics is broad in its interests, it embraces clinical, 
organizational and community levels of ethical issues. From its 
earliest stirrings, bioethics has paid considerable attention to 
ethical issues related to new scientific techniques such as Human 
Genome Project (HGP), cloning, and Genetically Modified 
Organisms (GMOs).  
 
1. Human Genome Project (HGP) 
The aim of the HGP is to provide scientists with powerful new 
tools to help them clear the research hurdles that now keep them 
from understanding the molecular essence of other tragic and 
devastating illnesses. Gene mutations probably play a role in 
many of today's most common diseases, such as heart disease, 
diabetes, immune system disorders, and birth defects. These 
diseases are believed to result from complex interactions 
between genes and environmental factors. When genes for 
diseases have been identified, scientists can study how specific 
environmental factors, such as food, drugs, or pollutants interact 
with those genes. Any project regarding this Human Genome 
(HG) means to identify the full set of genetic instructions 
contained inside our cells and to read the complete text written in 
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acid). As part of this project, biologists, chemists, engineers, 
computer scientists, mathematicians, and other scientists could 
able to work together to plot out several types of   biological 
maps that will enable researchers to find their way through the 
labyrinth of molecules that define the physical traits of a human 
being. Packed tightly into nearly every one of the several 
trillion/billion body cells is a complete copy of the human 
"genome" – all the genes that make up the master blueprint for 
building a man or woman. One hundred thousand or so genes 
impound inside the nucleus of each cell are parceled among the 
46 sausage-shaped genetic structures known as chromosomes. 
New maps developed through the Human Genome Project will 
enable researchers to pinpoint specific genes on our 
chromosomes. The most detailed map will allow scientists to 
translate the genetic instructions encoded in the estimated 3 
billion base pairs of nucleotide bases that make up human DNA. 
The development of gene-splicing techniques over the past 20 
years has given scientists remarkable opportunities to understand 
the molecular basis how a cell functions, not only in disease, but 
in everyday activities as well using these techniques, scientists 
have mapped out the genetic molecules, or genes, that control 
many life processes in common microorganisms. Human 
Genome Project is normally take 10-25 years to complete and 
consists of two major components. The first - creating maps of 
the 23 pairs of chromosomes - should be completed in the first 5 
to 10 years. The second component is sequencing the DNA 
contained in all the chromosomes will probably require the full 
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Advantages: 
 Human Genome Project research will help solve one of the 
greatest mysteries of life:  
 Fertilized Eggs: One fertilized egg is known to give rise to so 
many different specialized cells, such as those making up 
muscles, brain, heart, eyes, skin, blood, and so on. 
 Health Disorders: Most inherited diseases are rare, but taken 
together; the more than 3000 disorders known to result from 
single altered genes rob millions of healthy and productive 
lives.  
 Gene Structure: Having a gene in hand allows scientists to 
study its structure and characterize the molecular alterations, 
or mutations that result in disease.  
 Location of gene: Progress in understanding the causes of 
cancer, for example, has taken a leap forward by the recent 
discovery of cancer genes. Once a gene is located on a 
chromosome and its DNA sequence worked out, scientists 
can then determine which protein the gene is responsible for 
making and find out what it does in the body.  
 
 Disadvantages: 
 Although DNA sequencing technology has advanced rapidly 
over the past few years, it is still too slow  
 It is costly to use for sequencing even the amount of DNA 
contained in a single human chromosome.  
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Ethical Issues of the Human Genome Project 
Human Genome Project emphasized sequencing the entire 
human genome.  This goal, however, is controversial because of 
the high cost and because many critics believe that sequencing of 
huge amount of non-coding DNA should have low priority in a 
time of limited funds for research. Only about 5 percent of the 
genome contains sequences that their coding regions are most 
likely to contain information valuable to the medical and 
biological communities. Some biologists still argue that there is 
little point in sequencing the other 95 percent. A major criticism 
of the HGP is similar to that raised against other mega-science 
projects such as the space station or the superconducting 
supercollider: This big science vs. little science argument 
maintains that funding such large-scale projects takes scarce 
resources from researchers who may study certain areas of 
particular interest more efficiently. Some critics suggest that the 
ability to diagnose a genetic disorder before any treatment is 
available does more harm than good because it creates anxiety 
and frustration. Indeed, geneticists have isolated several disease-
causing gene mutations and have studied them in detail without 
developing a treatment. For example, the mutation in the beta-
globins' gene that results in sickle cell disease was identified in 
1956, but there is no treatment yet. Because of the genetic 
variation between individuals, there never will be one definitive 
human sequence. The lack of a definitive sequence creates 
uncertainty about the appropriate definition of "normal," which 
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2. Cloning 
The scientists of the world define cloning in different ways.  To 
use a specific definition, the American Medical Association 
(AMA) defined cloning as “the production of genetically 
identical organisms via somatic cell nuclear transfer.  ‘Somatic 
cell nuclear transfer’ refers to the process which the nucleus of a 
somatic cell of an existing organism is transferred into an oocyte 
from which the nucleus has been removed” (Council on Ethical 
and Judicial Affairs).    
In other words, cloning is the method of produce a baby that has 
the same genes as its parent.  Simply take an egg and remove its 
nucleus, which contains the DNA/genes.  Then take the DNA 
from an adult cell and insert it into the egg, either by fusing the 
adult cell with the nucleated egg, or by a sophisticated nuclear 
transfer.  Further more stimulate the reconstructed egg 
electrically or chemically and try to make it start to divide and 
become an embryo. Then use the same process to implant the 
egg into a surrogate mother that would use with artificial 
insemination. However, many groups defined cloning is the 
production of tissues and organs through growing cells or tissues 
in cultures along with the actual producing of embryos to be 
born with the use of stem cells.  When an egg is fertilized and it 
begins to divide, the cells are all the same.  As the cells divide, 
certain cells differentiate and become the stem cells that produce 
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Potential Medical Benefits: 
 The possibility that through cloning technology we will learn 
to renew activity of damaged cells by growing new cells and 
replacing them. 
 The capability to create humans with identical genetic 
makeup to act as organ donors for each other, i.e., kidney and 
bone marrow transplants. 
 The benefit of studying cell differentiation at the same time 
that cloning is studied and developed. 
 Sterile couples will be able to have offspring will have either 
the mother’s or father’s genetic pattern.  
 
 Potential Harms and Disadvantages 
 The possibility of compromising individualities. 
 Loss of genetic variation. 
 A “black market” of fetuses may arise from desirable donors 
that will want to be able to clone themselves, i.e., movie 
stars, athletes, and others. 
 Technology is not patented yet.  It has a low fertility rate.  In 
cloning Dolly, 277 eggs were used, 30 started to divide, nine 
induced pregnancy, and only one survived. 
 The clone would be a human being and deserve all the rights 
and privileges that a non-cloned human has.  A clone should 
not be a second-class citizen. 
 Unknown psychosocial harms with impacts on the family and 
society. 
 Producing clones for research or using their parts is unethical. 
 It would be against the code of ethics of a doctor to harm a 
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Ethical Issues in Human Cloning   
The successful cloning of an adult sheep, announced in Scotland, 
is one of the most dramatic recent examples of a scientific 
discovery becoming an issue to discuss among the scientists and 
theologians, physicians and legal experts, talk-radio hosts and 
editorial writers. They have been busily responding to the news, 
some calming fears, and other raising alarms about the prospect 
of cloning a human being.  
We just simply do not know the harms that will come from 
cloning. Cloning would lead to the loss of individuality because 
one’s genetic predispositions and conditions would be known. 
 However, the human clones could differ greatly in personality 
and even grow up with different conditions than the cloned.  This 
could be a great stress to the clone and possibly even the loss of 
ability to choose for itself and arise following concerning 
possible problems with mutations and clones. Since the somatic 
cell from which clones originate likely will have acquired 
mutations. Although these mutations might not be apparent at the 
time of cloning, genetics problems could become exacerbated in 
future generations.  
The cloning can possibly change the gene pool from how we 
now know it.  Most likely, it would not be a good change. 
Technology as we presently know it will not effectively support 
the cloning of humans. The success rate was quite low when 
cloning Dolly. Only one of the 277 tries succeeded. The same 
problems of the difficulty of having the fertilized egg implant 
parallels with that in vitro fertilization.  Technology has not yet 
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Some opponents of cloning believe that such individuals would 
be wronged in morally significant ways. For example, a child 
might be constantly compared to the adult from whom he was 
cloned, and thereby burdened with oppressive expectations. 
Even worse, the parents might actually limit the child's 
opportunities for growth and development: a child cloned from a 
basketball player, for instance, might be denied any educational 
opportunities that were not in line with a career in basketball. 
Finally, regardless of his parents' conduct or attitudes, a child 
might be burdened by the thought that he is a copy and not an 
"original". The child's sense of self-worth or individuality or 
dignity, so some have argued, would thus be difficult to sustain. 
There is also the fear that some would want to clone people to 
create large armies of the same soldier or even produce large 
amounts of workers. This would also lead to the creation of a 
second and lower class for clones. In other words, the power to 
create humans is only to be used in a marriage between husband 
and wife.   
There is a natural sentiment that is offended by the mental 
picture of identical babies being produced in some biological 
factory." Which raises the question: once people learn that this 
picture is mere science fiction, does the offense that cloning 
presents to "natural sentiment" attenuate, or even disappear? 
Some argued that the critics' fears -- or at least, those fears that 
merit consideration in formulating public policy -- dissolve once 
genetic determinism is refuted. People might continue to express 
concerns about the interests and rights of human clones, about 
the social and moral consequences of the cloning process, and 
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Yet it seems clear that some of these concerns, at least, are 
based on false beliefs about genetic influence and the nature of 
the individuals that would be produced through cloning. 
Consider, for instance, the fear that a clone would not be an 
"individual" but merely a "carbon copy" of someone else -- an 
automaton of the sort familiar from science fiction. As many 
scientists have pointed out, a clone would not in fact be an 
identical copy, but more like a delayed identical twin. In 
addition, just as identical twins are two separate people-
biologically, psychologically, morally and legally, though not 
genetically - so, too, a clone would be a separate person from her 
non-contemporaneous twin. To think otherwise is to embrace a 
belief in genetic determinism - the view that genes determine 
everything about us, and that environmental factors or the 
random events in human development are insignificant. We must 
also remember that children are often born in the midst of all 
sorts of hopes and expectations; the idea that there is a special 
burden associated with the thought "There is someone who is 
genetically just like me" is necessarily speculative. Moreover, 
given the falsity of genetic determinism, any conclusions a child 
might draw from observing the person from whom he was 
cloned would be uncertain at best. His knowledge of his future 
would differ only in degree from what many children already 
know once they begin to learn parts of their family's (medical) 
history. Some of us knew that we would be bald, or to what 
diseases we might be susceptible. To be sure, the cloned 
individual might know more about what he or she could become. 
















Quarterly Journal of Medical Ethics          Vol 2, No 5, Fall 2008 
on development is so incomplete, the clone would certainly be in 
for some surprises. Even if we were convinced that clones are 
likely to suffer particular burdens that would not be enough to 
show that it is wrong to create them. The child of a poor family 
can be expected to suffer specific hardships and burdens, but we 
do not thereby conclude that such children should not be born. 
Despite the hardships, poor children can experience parental love 
and many of the joys of being alive: the deprivations of poverty, 
however painful, are not decisive. More generally, no one's life 
is entirely free of some difficulties or burdens. In order for these 
considerations to have decisive weight, we have to be able to say 
that life does not offer any compensating benefits. Concerns 
expressed about the welfare of human clones do not appear to 
justify such a bleak assessment. Most such children can be 
expected to have lives well worth living; many of the imagined 
harms are no worse than those faced by children that have been 
acceptably produced by more conventional means. If there is 
something deeply objectionable about cloning, it is more likely 
to be found by examining implications of the cloning process 
itself, or the reasons people might have for availing themselves 
of it. 
Human cloning falls conceptually between two other 
technologies. At one end, we have the assisted reproductive 
technologies, such as in vitro fertilization, whose primary 
purpose is to enable couples to produce a child with whom they 
have a biological connection. At the other end we have the 
emerging technologies of genetic engineering - specifically, gene 
transplantation technologies - whose primary purpose is to 
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cloning see it as part of the first technology: cloning is just 
another way of providing a couple with a biological child they 
might otherwise be unable to have. Since this goal and these 
other technologies are acceptable, cloning should be acceptable 
as well. On the other hand, many opponents of cloning see it as 
part of the second technology: even though cloning is 
transplantation of an entire nucleus and not of specific genes, it 
is nevertheless an attempt to produce a child with certain traits. 
The deep misgivings we may have about the genetic 
manipulation of offspring should apply to cloning as well. 
To see what can be learned from such a comparative approach, 
let us consider a central argument that has been made against 
cloning - that it undermines the structure of the family by 
making identities and lineages unclear. On the one hand, the 
relationship between an adult and the child cloned from her 
could be described as that between a parent and offspring. 
Indeed, some commentators have called cloning "asexual 
reproduction," which clearly suggests that cloning is a way of 
generating descendants. The clone, on this view, has only one 
biological parent. On the other hand, from the point of view of 
genetics, the clone is a sibling, so that cloning is more accurately 
described as "delayed twinning" rather than as asexual 
reproduction. The clone, on this view, has two biological 
parents, not one - they are the same parents as those of the 
person from whom that individual was cloned. 
Cloning thus results in ambiguities. Is the clone an offspring or a 
sibling? Does the clone have one biological parent or two? The 
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many societies, including our own, lineage identifies 
responsibilities. Typically, the parent, not the sibling, is 
responsible for the child. However, if no one is unambiguously 
the parent, so the worry might go, who is responsible for the 
clone? Insofar as social identity is based on biological ties, will 
not this identity be blurred or confounded? A surrogate mother 
may be required to relinquish all parental claims to the child she 
bears. In these cases, the social and legal determination of "who 
is the parent" may appear to proceed in defiance of profound 
biological facts, and to subvert attachments that we as a society 
are ordinarily committed to upholding. Thus, while the aim of 
assisted reproductive technologies is to allow people to produce 
or raise a child to whom they are biologically connected, such 
technologies may also involve the creation of social ties that are 
permitted to override biological ones. To some critics, 
admittedly, this difference will not seem terribly important. 
Some objects to cloning on the grounds that children created 
through this technology would be "designed as a product" rather 
than "welcomed as a gift." The fact that the design process 
would be more selective and nuanced in the case of genetic 
engineering would have no moral significance from this 
perspective.  
 
3. Environmental and Ecological Risks on GMOs and GM 
Food 
Genetically modified organisms (GMOs) can be defined as 
organisms in which the genetic material (DNA) has been altered 
in a way that does not occur naturally. The technology is often 
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also “recombinant DNA technology” or “genetic engineering”. It 
allows selected individual genes to be transferred from one 
organism into another, also between non-related species to either 
the producer or consumer of these foods. This is meant to 
translate into a product with a lower price, greater benefit (in 
terms of durability or nutritional value) or both. Initially GM 
seed developers wanted their products to be accepted by 
producers so have concentrated on innovations that farmers (and 
the food industry more generally) would appreciate. The initial 
objective for developing plants based on GM organisms was to 
improve crop protection. The GM crops currently on the market 
are mainly aimed at an increased level of crop protection through 
the introduction of resistance against plant diseases caused by 
insects or viruses or through increased tolerance towards 
herbicides. Insect resistance is achieved by incorporating into 
the food plant the gene for toxin production from the bacterium 
Bacillus thuringiensis (BT). This toxin is currently used as a 
conventional insecticide in agriculture and is safe for human 
consumption. GM crops that permanently produce this toxin 
have been shown to require lower quantities of insecticides in 
specific situations, e.g. where pest pressure is high. Virus 
resistance is achieved through the introduction of a gene from 
certain viruses that cause disease in plants. Virus resistance 
makes plants less susceptible to diseases caused by such viruses, 
resulting in higher crop yields. 
 
Herbicide tolerance is achieved through the introduction of a 
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In situations where weed pressure is high, the use of such crops 
has resulted in a reduction in the quantity of the herbicides used. 
Generally, consumers consider that traditional foods (that have 
often been eaten for thousands of years) are safe. When new 
foods are developed by natural methods, some of the existing 
characteristics of foods can be altered, in either a positive or a 
negative way National food authorities may be called upon to 
examine traditional foods, but this is not always the case. Indeed, 
new plants developed through traditional breeding techniques 
may not be evaluated rigorously using risk assessment 
techniques. With GM foods, most national authorities consider 
that specific assessments are necessary. Specific systems have 
been set up for the rigorous evaluation of GM organisms and 
GM foods relative to both human health and the environment. 
Similar evaluations are generally not performed for traditional 
foods. Hence, there is a significant difference in the evaluation 
process prior to marketing for these two groups of food. 
While theoretical discussions have covered a broad range of 
aspects, the three main issues debated are tendencies to provoke 
allergic reaction (allergenicity), gene transfer and outcrossing. 
Gene transfer from GM foods to cells of the body or to bacteria 
in the gastrointestinal tract would cause concern if the 
transferred genetic material adversely affects human health. This 
would be particularly relevant if antibiotic resistance genes, used 
in creating GMOs, were to be transferred. The movement of 
genes from GM plants into conventional crops or related species 
in the wild (referred to as “outcrossing”), as well as the mixing 
of crops derived from conventional seeds with those grown using 
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security. Several developed countries including USA and UK 
have adopted strategies to reduce mixing, including a clear 
separation of the fields within which GM crops and conventional 
crops are grown. Feasibility and methods for post-marketing 
monitoring of GM food products, for the continued surveillance 
of the safety of GM food products, are under discussion. 
There is growing concern about environmental issues, which 
must be welcome by all who are concerned about environmental 
ethics and justice to current and future generations. Nevertheless, 
any biotechnology that is in conflict with the moral issue and 
sustainability principle will be called "unethical". Biotechnology 
has potential for ecological improvement, if applications are 
targeted with that objective. The ecological alarming make 
people concern about the introduction of new organisms into the 
environment, including GMOs. Ecological studies are needed, 
and monitoring of releases of GMOs, to gain data to allow 
prediction of the ecological impact of such introductions. We 
should support program that are designed to provide methods to 
monitor the release and survival of GMOs. It appeals to our 
sense of values based on human utility. There is a further way to 
argue for the protection of nature and the environment, and it is a 
more worthy paradigm. It is that nature has value for itself 
because it is there. We should not damage other species, unless it 
is absolutely necessary for the survival of human beings (not the 
luxury of human life).Nature has life, thus it has some value. 
Another paradigm for looking at the world is a religious view, 
that God made the world so the world has value. Moreover, we 
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people live in a better way than if they look at the world only 
with the paradigm of human benefit. There needs to be 
examination of the view of nature that different people have, so 
that we can find what the commonly acceptable limits to 
modification of nature, plant and animal varieties, and human 
beings are. In the modern world any new science can easily 
spread, so researchers are accountable to all peoples of the 
world. Field releases of GMOs are regulated in all countries of 
the world, officially, as they should be. The procedures vary, as 
does the public satisfaction with such procedures. They are also 
subject to political climate, and bureaucratic regulations conflict 
with industry and with the principle of beneficence, whereas 
inadequate regulations risky and harmful.  
 
 Ethical Issues in GMOs and GMF 
The reasons cited for the unacceptability of genetic manipulation 
of organisms and food can be grouped into two major categories:  
 Fear of unknown 
 Unknown health concerns  
 
Fear of Unknown 
In general, most of the Bioethicists always predicted that all 
organisms were connected with the unknown nature or danger of 
the results of genetic manipulation. Some people saw this in 
terms of a disaster, while others have less dramatic concerns. 
There is also fear associated with unknown research fields, 
which is true of any area. We could subdivide this concern into 
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Unknown health concerns 
Many Bioethicists may see these techniques as unacceptable, 
regardless of the state of technology and regulation. The 
questions about food also illustrate this concern. In developed 
countries like Japan, Canada, Australia 12-16% of the public 
who were concerned about concerning products made from 
GMOs, said that such foodstuffs or medicines would be 
unnatural. While in public survey in Britain, 70% agreed that 
"natural vitamins are better for us than laboratory-made ones" 
only 18% disagreed. In fact, rationally we can say such foods are 
just as natural as foods made from any modern crop or animal 
breed.   
 
E.  Ethical Criteria for Biotechnological Research  
The following criteria might be useful in determining whether 
biotechnological research is ethical.  
 What is the benefit? To whom? Is it life saving? Human 
benefit is greater than monetary benefit.  
 Do no harm to humans. What is an acceptable level of risk? 
Follow ethical codes on free and informed consent for human 
experimentation.  
 Do not cause pain. Protect animal rights as much as possible, 
use less sentient/conscious to animals for research, and 
develop non-animal alternatives.  
 Independent open decision-making on safety questions, 
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 Inform and educate the public and scientists about all 
dimensions of the projects, scientific, social, economic and 
ethical, using third party media.  
 Do no harm to the environment. Use the technology that is 
most environmentally sustainable over the long-term. 
 Minimize consumption, may need to introduce environmental 
quotas to do this according to just distribution of global assets 
and introduce maximum levels for individual production of 
pollution.  
 Protect biodiversity. Protect endangered species. Allow 
farmers affordable or free access to breeding stock, and 
encourage planting of diverse crops.  
 Justice to all people, and future generations. Share benefits 
and risks. 
 Bioethics still needs to be developed in order to approach this 
abstract area of thinking.  
 Scientists as well as the public perceive limits to what are 
acceptable, or "ethical", biotechnology, and further research 
is needed to determine what these limits are.  
 
Possible Major Laws and Principles in Biotechnology  
Biotechnology can provide useful tools for combating disease, 
hunger and environmental contamination, but it should not be 
viewed as a universal remedy or as miraculous. For example, 
life-saving medicines may have serious side effects, and, while 
our expanding knowledge of genetics can help create the next 
generation of medicines, it can also raise important ethical 
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to impose in Government Law and regulations throughout the 
world. 
 
1. Realization and Approbation of Biotechnology and apply 
it for the Benefit of Human Being 
The resolution of bioethical issues requires broad public 
discourse. The Government of any country can acknowledge 
their responsibility to consider the interests and ideas of all 
segments of society and to be sensitive to cultural and religious 
differences. Biotechnologists will pursue applications of 
biotechnology that promise to save lives or improve the quality 
of life. Biologists, technologists and economists will seek 
dialogue with patients, ethicists, religious leaders, health care 
providers, environmentalists, consumers, legislators, and other 
groups who share an interest in bioethical issues. 
2. Awareness of Biotechnology and its Benefits and 
Implications towards the Public  
The public and the elected representatives of the National 
Biotechnology Directorate of each country need greater 
knowledge and a better understanding about biotechnology and 
its applications. The relevant authorities should have better 
understanding and interactions among themselves. All the 
Research Universities, Biotech Research Institutes and Biotech 
Industry will disseminate their research findings for the benefit 
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3.  Privacy in Genetic Information 
Individually identifiable medical information must be treated 
confidentially and safeguarded from misuse. We should oppose 
the use of medical information to promote intolerance, 
discriminate against or to stigmatize people. 
4. Priority Areas Focus for New Products to Safe Guard 
Health 
Priority should be given to the potential areas of health and 
environmental protection in the developed countries. The 
procedure can be the model of other developed countries e.g. 
United States, UK, Canada, biotech products are extensively 
regulated by federal agencies such as the Food and Drug 
Administration, the Environmental Protection Agency and the 
Department of Agriculture. As such, Malaysia also supports 
science-based regulation by government agencies to safeguard 
health, ensure safety and protect the environment. 
5. Respect and Treat the Laboratory Animals Humanely 
Laboratory animals are essential to research on new therapies 
and cures. The concern researchers should test new treatments on 
laboratory animals to assess product safety before administering 
them to humans. Student can develop "transgenic" animals -- 
those with genes from another species, usually humans -- to test 
treatments for life-threatening diseases. The National Biotech 
Directorate will follow rigorously all government regulations 
and professional standards in the Malaysia, such as the Animal 
Welfare Act and the federal guidelines for animal care and use 
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6. Awareness on Ethical and Social issues regarding Genetic 
Research 
The treatment on genetic disorders by altering the genes of 
human sperm or eggs until the medical, ethical and social issues 
that will arise from this kind of therapy have been more broadly 
discussed and clarified. Also, we support continuation of the 
voluntary moratorium on the potential cloning of entire human 
beings, with the understanding that research should continue on 
the cloning of genes and cells to benefit humankind.  
7. Ethical Standards 
At present the developing countries will abide by the ethical 
standards of the authorized developed countries such as 
American Medical Association and UK Medical Association, 
where appropriate, other health care professional societies to 
ensure that the products are appropriately prescribed, dispensed 
and used. 
8. Promote Sustainable Agriculture with Environmental 
Benefits 
Farmers must produce increasing amounts of food per acre to 
feed a growing global population. As because there are 
significant advantages to increasing the yield of crops the 
biotechnologists will strive to make this possible while reducing 
the amount of external supplements (fertilizers, pesticides, etc.) 
necessary.  
9. Utilization of  Bioremediation to Clean up Hazardous 
Waste  
Develop the method for using biotechnology to harness the 
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at hazardous waste sites. The research will strive to optimize the 
cost efficiencies and environmental advantages associated with 
using biotechnology while protecting human health and the 
environment. These could include the development and 
implement more environmentally safe and cost-effective means 
of treating hazardous waste streams in industrial processes.  
10.  Conservation of Biological Diversity 
The genetic variation of animals, plants and other organisms is a 
valuable natural resource. The environment is constantly 
changing, and without an adequate store of genetic diversity, 
organisms will not be able to adapt. Genetic diversity decreases, 
however, every time a species, breed or crop variety becomes 
extinct. The governments along with other research 
organizations could develop a data base catalog to conserve 
these precious resources.  
11. Avoid Biotechnology for Bioterrorism 
Biotechnologists should strongly support the Biological 
Weapons Convention, a treaty signed by the United States and 
many other nations banning development and use of biological 
weapons.  
  
F. Biotechnology in Islamic Perspectives 
The doubt rising now a days against the biotechnical solutions to 
the problem of infertility, invitro fertilization and genomes-
genetic engineering aspects (Cloning) - whether they are justified 
or not. Now a days question arises whether they tamper with the 
Sunan (Ways) of the Almighty Allah? It is true that such 
technologies may be abused. However, we should look at the 
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numerous benefits if used correctly and can prove disastrous if 
misused. Now a technology to resolve infertility cannot be 
condemned outright as being against the Sunan of Almighty 
Allah since infertility, should be viewed as defect or disease. It 
seems that cloning would not fall under the category of trying to 
resolve the problem of infertility. It should be used for the 
satisfaction of one’s own personal ego – to have clone of one. 
Reproductive cloning is too dangerous, and raises far too many 
ethical and social questions. Producing children in that manner 
would be threaten the very institution of marriage, and in view of 
that would be an illegal venture under Islamic law. 
Research is also going on regarding the environmental cues, 
genes and structures that direct cell differentiation into whole 
organs composed of different tissue types. Because of somatic 
cell nuclear transfer cloning, the tissues and organs would be 
genetically identical to the patient and, therefore, would not be 
rejected. This application of cloning technology is often referred 
to as therapeutic cloning, or somatic cell nuclear transfer 
(SCNT). God has commanded that the sacred powers of 
procreation are to be employed only between man and woman, 
lawfully wedded as husband and wife”.  Cloning only involves 
one parent, therefore it is not following God’s plan in which a 
man’s sperm and a woman’s egg are needed to create life. So 
cloning of a person is definitely against almighty’s law. 
Undifferentiated cells that are genetically identical to the patient 
have remarkable therapeutic potential.  
Given the proper environments, these cells could develop into 
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such as diabetes, Parkinson's, Alzheimer's and various types of 
cancer and heart disease. This avenue of study could produce 
replacement skin, cartilage and bone tissue for burn victims and 
nerve tissue for those with spinal cord or brain injuries. The 
remarkable potential of cellular cloning is to cure diseases and 
restore function to diseased tissues. Therefore, Muslim Scientists 
can support the application of cloning for only therapeutic cases 
but not other purposes. 
 
G.  Conclusion and Recommendation 
Genetic manipulation especially cloning is a wonderful 
advancement in technology and knowledge. Professional and 
scientific societies should make clear that any attempt to create a 
child by somatic cell nuclear transfer and implantation into a 
woman's body would be at this time be an irresponsible, 
unethical, and unprofessional act. Federal and state legislation 
should be enacted to prohibit anyone from attempting, whether 
in a research or clinical setting, to create a child through somatic 
cell nuclear transfer cloning. The federal government of all the 
countries and all interested and concerned parties encourage 
widespread and continuing deliberation on these issues. In order 
to further understanding of the ethical and social implications of 
this technology and to enable society to produce appropriate 
long-term policies regarding this technology should the time 
come when present concerns about safety have been addressed. 
Federal departments and agencies concerned with science should 
cooperate in seeking out and supporting opportunities to provide 
information and education to the public in the area of genetics, 
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where these affect important cultural practices, values, and 
beliefs. Government and scientists should try to develop other 
ways beside the natural way to bring life into this world. It 
would be advantageous to science and medicine to clone tissues 
and organs.  
While the environmental risks assessments of genetically 
modified organisms, (GMOs) should cover both the GMO 
concerned and the potential receiving environment. The 
assessment process should include evaluation of the 
characteristics of the GMO and its effect and stability in the 
environment, combined with ecological characteristics of the 
environment in which the introduction will take place. The 
environmental safety aspects of GM crops vary considerably 
according to local conditions. The investigations should focus on 
the potentially detrimental effect on beneficial insects or a faster 
induction of resistant insects; the potential generation of new 
plant pathogens; the potential detrimental consequences for plant 
biodiversity and wildlife, and a decreased use of the important 
practice of crop rotation in certain local situations; and the 
movement of herbicide resistance genes to other plants.  
Different GM organisms include different genes inserted in 
different ways. This means that individual GM foods and their 
safety should be assessed on a case-by-case basis and that it is 
not possible to make general statements on the safety of all GM 
foods. GM foods are currently available on the international 
market have passed risk assessments and are not likely to present 
risks for human health. An improved and harmonized framework 
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Need to examine the potential negative effects on human health 
of the consumption of food produced through genetic 
modification, also at the global level. Such evaluations must be 
holistic and all-inclusive focusing on human health and 
environmental effects. It is hoped that the assessment report 
could form the basis for a future initiative towards a more 
systematic, coordinated, multi-organizational and international 
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